The Emergence of Turbo Cancer: A New Pandemic?
Pfizer CEO Albert Bourla has expressed concerns about a new health threat known as turbo cancer. Observations suggest that booster shots of mRNA vaccines may activate dormant cancers and viruses within the body. This alarming trend is being noticed by medical professionals and is under scientific investigation. Researchers are delving into the reasons why individuals who receive mRNA vaccine boosters, such as those from Pfizer and Moderna, seem more prone to viral infections, including Shingles. More alarmingly, some oncologists are reporting cases of previously stable cancers becoming aggressive following a vaccine booster shot, a phenomenon now termed “turbo cancer.”
Understanding the Dual Immune Systems
Humans possess two immune systems: the innate system, which is present from birth and includes T-cells that combat foreign cells, and the adaptive system, which produces specific antibodies from B-cells in response to infections. These systems work in conjunction and prepare the body to tackle larger threats.
Impact of COVID-19 Vaccine on Immune Function
A 2021 study from the Radboud Centre for Infectious Diseases in the Netherlands titled ‘The BNT162b2 mRNA vaccine against SARS-CoV-2 reprograms both adaptive and innate immune responses’ highlighted concerns regarding the vaccine’s long-term effects on the immune system. Although the vaccine showed efficacy against several COVID-19 variants, its protection diminished after six months. The study found that the BNT162b2 vaccine induced complex changes in the innate immune response, affecting receptors on T-cells, dendritic cells, macrophages, and suppressor cells. These changes can compromise the body’s ability to fight not only COVID-19 but also other viruses and cancers.
The Role of Toll-Like Receptors
Toll-like receptors (TLRs) are critical proteins within the innate immune system. TLRs 7 and 8 are responsible for keeping viruses like Herpes 8, Epstein Barr, and Shingles under control, but post-vaccination, these viruses may be reactivated. Additionally, TLR4 helps to suppress cancer, and if this receptor is downregulated or turned off, the immune response against cancer is weakened.
Spike Protein and Immune Response in Cancer
There is evidence suggesting that spike protein can damage healthy cell processes, potentially leading to genome instability and cancer progression. The interaction between SARS-CoV-2 and tumor suppressor proteins has been documented, raising questions about whether vaccine spike proteins could have similar effects.
Oncologists’ Observations and the Term “Turbo Cancer”
Renowned oncologist Professor Angus Dalgleish has voiced his concerns about the adverse effects of booster shots, particularly in young adults and children. He has observed dormant cancers, especially B-cell cancers, reawakening shortly after booster shots. Reports from oncologists around the world corroborate the sudden and extreme progression of cancers post-vaccination, leading to the term “turbo cancer.”
Pharmaceutical Industry’s Response to Turbo Cancer
Albert Bourla of Pfizer has been discussing the company’s expansion into oncology, particularly following the acquisition of Seagen, a company specializing in drugs targeting turbo cancer. Bourla anticipates that a significant portion of the population may develop turbo cancer in the future, and Pfizer plans to provide treatments at an unprecedented scale.
Conclusion and Additional Observations
While some may dismiss the concerns about turbo cancer as conspiracy theories, the evolving situation and pharmaceutical companies’ actions suggest otherwise. Pfizer’s acquisitions in the fields of oncology and cardiovascular treatments, including for conditions linked to mRNA COVID-19 vaccines, indicate a strategic shift in response to emerging health challenges.
